ДИНАМИКА СОДЕРЖАНИЯ СЫВОРОТОЧНЫХ МАРКЕРОВ АПОПТОЗА ДЛЯ ОЦЕНКИ ПРОГНОЗА ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У ДЕТЕЙ
https://doi.org/10.15690/vsp.v12i5.807
Аннотация
Об авторах
О. В. КомароваРоссия
А. Г. Кучеренко
Россия
И. Е. Смирнов
Россия
А. Н. Цыгин
Россия
Список литературы
1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39 (2 Suppl. 1): 1–266.
2. Smirnov A. V., Dobronravov V. A., Kayukov I. G. et al. Khroniches kaya Bolezn' Pochek: Dal'neyshee Razvitie Kontseptsii i Klassifikatsii [Chronic Kidney Disease: Further Development of the Concept and Classification]. Nefrologiya [Nephrology]. 2007; 11 (4): 7–17.
3. Fogo A. B. Mechanisms of progression of chronic kidney disease. Pediatr. Nephrol. 2007; 2: 2011–2022.
4. Bohle A., Muller G. A., Wehrmann M. et al. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Am. J. Kidney Dis. 1996; 49 (Suppl.): 2–9.
5. Komarova O. V., Kucherenko A. G., Smirnov I. E., Tsygin A. N. Rol' Narusheniy Protsessov Apoptoza v Progressirovanii Khronicheskoy Bolezni Pochek u Detey [Role of Apoptosis Disorders in the Progression of Chronic Kidney Disease in Children]. Nefrologiya i dializ [Nephrology and Dialysis]. 2013; 15: 135–139.
6. Shirokova A. V. Apoptoz. Signal'nye Puti i Izmenenie Ionnogo i Vodnogo Balansa Kletki [Apoptosis. Signaling Pathways and Changes in Ion and Water Balance of the Cell]. Tsitologiya [Cytology]. 2007; 49 (5): 385–394.
7. Jaber B. L., Perianayagam M.C., Balakrishnan V. S., King A. J. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system. J. Leuk. Biol. 2001; 69 (6): 1006–1012.
8. Green D. R., Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004; 305 (5684): 626–629.
9. Dounousi E., Koliousi E., Papagianni A. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease. Am. J. Nephrol. 2012; 36: 531–536.
10. Hughes J., Savill J. S. Apoptosis in glomerulonephritis. Curr. Opin. Nephrol. Hypertens. 2005; 14 (4): 389–395.
11. Tao Y., Kim J., Stanley M. et al. Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int. 2005; 67: 909–919.
12. Moiseev S. V., Arutyunov G. P., Fomin V. V. Ingibitory APF i Nefroprotektsiya pri Khronicheskikh Zabolevaniyakh Pochek s Proteinuriey [ACE Inhibitors and Nephroprotection at Chronic Kidney Disease with Proteinuria]. Klinicheskaya Nefrologiya [Clinical Nephrology]. 2009; 2: 31–36.
13. Bakris G. L. Slowing nephropathy progression: focus on proteinuria reduction. Clin. J. Am. Soc. Nephrol. 2008; 3: 3–10.
14. Metcalfe W. How does early chronic kidney disease progress. Nephrol. Dial. Transplant. 2007; 22 (Suppl. 9): 26–30.
Рецензия
Для цитирования:
Комарова О.В., Кучеренко А.Г., Смирнов И.Е., Цыгин А.Н. ДИНАМИКА СОДЕРЖАНИЯ СЫВОРОТОЧНЫХ МАРКЕРОВ АПОПТОЗА ДЛЯ ОЦЕНКИ ПРОГНОЗА ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У ДЕТЕЙ. Вопросы современной педиатрии. 2013;12(5):104-107. https://doi.org/10.15690/vsp.v12i5.807
For citation:
Komarova O.V., Kucherenko A.G., Smirnov I.E., Tsygin A.N. DYNAMICS OF CONCENTRATION OF APOPTOSIS SERUM MARKERS IN ASSESSMENT OF PROGNOSIS OF CHRONIC KIDNEY DISEASE IN CHILDREN. Current Pediatrics. 2013;12(5):104-107. (In Russ.) https://doi.org/10.15690/vsp.v12i5.807